IQVIA Hldgs (NYSE: IQV)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-26 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.420 | 2.470 | 0.0500 | ||||
REV | 3.550B | 3.568B | 18.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of IQVIA Hldgs (NYSE: IQV) through any online brokerage.
Other companies in IQVIA Hldgs’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
The latest price target for IQVIA Hldgs (NYSE: IQV) was reported by Guggenheim on Tuesday, May 24, 2022. The analyst firm set a price target for 244.00 expecting IQV to rise to within 12 months (a possible 13.40% upside). 25 analyst firms have reported ratings in the last year.
The stock price for IQVIA Hldgs (NYSE: IQV) is $215.17 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for IQVIA Hldgs.
IQVIA Hldgs’s Q2 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for IQVIA Hldgs.
IQVIA Hldgs is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.